Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALPMY | ONC | UTHR | ||
| Company | Astellas Pharma ADR | Beone Medicines Ltd | United Therapeutic | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 16.3950 | 313.14 | 581.38 | ||
| High | 16.4700 | 320.30 | 584.54 | ||
| Low | 16.3500 | 311.25 | 575.00 | ||
| Latest | 16.4600 | 319.94 | 577.58 | ||
| Change | +0.4400 | +9.94 | -0.96 | ||
| % Change | +2.75% | +3.21% | -0.17% | ||
| Volume | 79,100 | 196,100 | 491,400 | ||
| 20-Day Average Volume | 144,515 | 220,440 | 660,735 | ||
| Previous Close | 16.0200 | 310.00 | 578.54 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.0080 | 295.58 | 556.77 | ||
| 20-Day Raw Stochastic | 67.52% | 99.26% | 66.44% | ||
| 20-Day Relative Strength | 57.46 | 55.86 | 60.54 | ||
| Weighted Alpha | +79.62 | +29.25 | +88.06 | ||
| Today's Opinion | 100% Buy | 32% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 24% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.32% since 04/08/26 | +2.48% since 04/08/26 | -0.71% since 04/08/26 | ||
| Low | 15.9100 on 04/14/26 | 302.53 on 04/13/26 | 566.12 on 04/10/26 | ||
| High | 16.9800 on 04/09/26 | 320.30 on 04/15/26 | 584.54 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +12.28% since 03/13/26 | +12.64% since 03/13/26 | +7.73% since 03/13/26 | ||
| Low | 14.3815 on 03/16/26 | 271.47 on 03/24/26 | 517.59 on 03/24/26 | ||
| High | 17.3500 on 03/30/26 | 320.30 on 04/15/26 | 607.89 on 03/30/26 | ||
| 3-Month | |||||
| %Chg | +15.75% since 01/15/26 | -5.42% since 01/15/26 | +22.37% since 01/15/26 | ||
| Low | 13.8100 on 01/20/26 | 271.47 on 03/24/26 | 455.63 on 01/20/26 | ||
| High | 17.3500 on 03/30/26 | 372.73 on 02/24/26 | 607.89 on 03/30/26 | ||
| 6-Month | |||||
| %Chg | +57.21% since 10/15/25 | +1.20% since 10/15/25 | +33.64% since 10/15/25 | ||
| Low | 10.0500 on 10/31/25 | 271.47 on 03/24/26 | 409.07 on 10/28/25 | ||
| High | 17.3500 on 03/30/26 | 385.22 on 11/17/25 | 607.89 on 03/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 28,990,802 | 34,013,200 | 25,356,244 | ||
| Shares Outstanding, K | 1,809,663 | 109,720 | 43,828 | ||
| Annual Sales | 12,621,330,000 | 5,343,030,000 | 3,182,700,000 | ||
| Annual Net Income | 334,930,000 | 286,930,000 | 1,334,700,000 | ||
| Last Quarter Sales | 3,708,270,000 | 1,498,170,000 | 790,200,000 | ||
| Last Quarter Net Income | 651,300,000 | 66,500,000 | 364,300,000 | ||
| 60-Month Beta | 0.17 | 0.53 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.44 on 02/04/26 | 0.58 on 02/26/26 | 7.70 on 02/25/26 | ||
| Latest Earnings Date | 04/24/26 | 05/06/26 | 04/29/26 | ||
| Most Recent Dividend | 0.170 on 09/26/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 09/26/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.52 | 81.94 | 20.70 | ||